This report focuses on the global Therapeutic Drug Monitoring status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Therapeutic Drug Monitoring development in United States, Europe and China. Therapeutic drug monitoring (TDM) is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication concentrations in blood. Its main focus is on drugs with a narrow therapeutic window. TDM aims at improving patient care by adjusting the dose of drugs for which clinical experience or clinical trials have shown it improved outcome in the general or special populations. It can be based on a priori pharmacogenetic, demographic and clinical information, and/or on the a posteriori measurement of blood concentrations of drugs. In 2018, North America is expected to account for the largest share of the global therapeutic drug monitoring market, while Asia Pacific is expected to grow at the highest rate during the forecast period. The dominant share of the North American market is attributed to its well-established pharmaceutical industry, the presence of leading pharmaceutical and biotechnology companies, favorable government funding, and high R&D investments in this region. In 2017, the global Therapeutic Drug Monitoring market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Abbott Laboratories Roche Siemens Healthineers Thermo Fisher Danaher Bio-Rad Laboratories Biomerieux Buhlmann Laboratories Sekisui Medical Randox Laboratories Market segment by Type, the product can be split into Antiepileptic Drugs Antiarrhythmic Drugs Immunosuppressant Drugs Antibiotic Drugs Bronchodilator Drugs Psychoactive Drugs Other Drug Classes Market segment by Application, split into Commercial/Private Labs Hospital Labs Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Therapeutic Drug Monitoring status, future forecast, growth opportunity, key market and key players. To present the Therapeutic Drug Monitoring development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Therapeutic Drug Monitoring are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (2013-2025) 1.4.2 Antiepileptic Drugs 1.4.3 Antiarrhythmic Drugs 1.4.4 Immunosuppressant Drugs 1.4.5 Antibiotic Drugs 1.4.6 Br
